Ricerca avanzata

Home > Riviste > Minerva Pneumologica > Fascicoli precedenti > Minerva Pneumologica 2014 Marzo;53(1) > Minerva Pneumologica 2014 Marzo;53(1):43-5

FASCICOLI E ARTICOLI   I PIÙ LETTI   eTOC

ULTIMO FASCICOLOMINERVA PNEUMOLOGICA

Rivista sulle Malattie dell’Apparato Respiratorio

Official Journal of the Italian Society of Thoracic Endoscopy
Indexed/Abstracted in: EMBASE, Scopus

Periodicità: Trimestrale

ISSN 0026-4954

Online ISSN 1827-1723

 

Minerva Pneumologica 2014 Marzo;53(1):43-5

 CASI CLINICI

Hepatotoxicity due to montelukast: a case-based review of literature

Sargin G. 1, Coskun A. 2, Yavasoglu I. 3, Yasa M. H. 2

1 Department of Internal Medicine Adnan Menderes University Medical Faculty Aydin, Turkey;
2 Division of Gastroenterology Adnan Menderes University Medical Faculty Aydin, Turkey;
3 Division of Hematology Adnan Menderes University Medical Faculty Aydın, Turkey

Montelukast is a selective antagonist of cysteinyl leukotriene receptors. Drug-induced hepatotoxicity and abnormal levels of serum aminotransferases may be detected in patients without any clinical symptoms. In literature, several side effects about montelukast have been reported with clinical sings such as jaundice etc. with elevated bilirubin levels. Here, we report 60-year-old female patient who had a medical history about montelukast receiving and elevated serum aminotransferases without any clinical sings.

lingua: Inglese


FULL TEXT  ESTRATTI

inizio pagina